EcoDrugPlus

Opioid Receptor, Kappa 1

Ensembl ID : ENSPMAG00000007633
Gene Symbol: OPRK1
2 Cross references
262 Possible Orthologues:

P21 Protein (Cdc42/rac)-Activated Kinase 4

Ensembl ID : ENSPMAG00000008567
Gene Symbol: PAK4
1 Cross references
163 Possible Orthologues:

Phosphatidylinositol-4,5-Bisphosphate 3-Kinase, Catalytic Subunit Delta

Ensembl ID : ENSPMAG00000002617
Gene Symbol: PIK3CD
1 Cross references
213 Possible Orthologues:

Phosphatidylinositol-4,5-Bisphosphate 3-Kinase, Catalytic Subunit Gamma

Ensembl ID : ENSPMAG00000002221
Gene Symbol: PIK3CG
1 Cross references
11 Possible Orthologues:

Phosphodiesterase 10a

Ensembl ID : ENSPMAG00000006792
Gene Symbol: PDE10A
1 Cross references
205 Possible Orthologues:

Phosphodiesterase 5a, Cgmp-Specific, B

Ensembl ID : ENSPMAG00000001676
Gene Symbol: PDE5AB
1 Cross references
264 Possible Orthologues:

Phosphodiesterase 7a

Ensembl ID : ENSPMAG00000008862
Gene Symbol: PDE7A
1 Cross references
253 Possible Orthologues:

Phosphodiesterase 9a

Ensembl ID : ENSPMAG00000000371
Gene Symbol: PDE9A
1 Cross references
278 Possible Orthologues:

Phosphoinositide-3-Kinase, Regulatory Subunit 1 (Alpha)

Ensembl ID : ENSPMAG00000003350
Gene Symbol: PIK3R1
1 Cross references
203 Possible Orthologues:

Platelet Activating Factor Acetylhydrolase 2

Ensembl ID : ENSPMAG00000003076
Gene Symbol: PAFAH2
1 Cross references
131 Possible Orthologues:

Potassium Inwardly Rectifying Channel Subfamily J Member 14

Ensembl ID : ENSPMAG00000010219
Gene Symbol: KCNJ14
1 Cross references
264 Possible Orthologues:

Potassium Inwardly Rectifying Channel Subfamily J Member 3

Ensembl ID : ENSPMAG00000000984
Gene Symbol: KCNJ3
1 Cross references
236 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).